John Moroney to Adenocarcinoma, Clear Cell
This is a "connection" page, showing publications John Moroney has written about Adenocarcinoma, Clear Cell.
Connection Strength
0.231
-
A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283. Gynecol Oncol. 2023 09; 176:16-24.
Score: 0.211
-
What is the benefit of bevacizumab combined with chemotherapy in patients with recurrent ovarian, fallopian tube or primary peritoneal malignancies? J Chemother. 2009 Nov; 21(5):566-72.
Score: 0.020